
Other research shows treatment leads to high patient satisfaction
Swallowing pills containing a concentrate of fecal bacteria successfully stops recurrent bouts of debilitating Clostridium difficile (C. diff) infection by rebalancing the bacteria in the gut, suggests a study being presented at the IDWeek 2013™ meeting today.
Infection from C. diff bacteria is such a concern that the Centers for Disease Control and Prevention (CDC) named it one of the three most urgent threats in its recent landmark report on antibiotic resistance. C. diff sickens half a million Americans and kills 14,000 every year. C. diff infection can occur after people take antibiotics, wiping out the good bacteria in the gastrointestinal (GI) system, allowing C. diff to flourish and leading to severe diarrhea. In some patients, infection continues to recur despite standard treatment with antibiotics. For patients trapped in that cycle, doctors have transplanted feces from healthy donors into their GI system to rebalance the bacteria and stop infections from recurring.
Fecal transplantation typically is delivered by enema, colonoscopy (placing a tube in the colon) or nose tube and is effective in nine out of 10 patients, according to published reports. The IDWeek research suggests the less-invasive pills are a viable and effective delivery method.
“Recurrent C. diff infection is such a miserable experience and patients are so distraught that many ask for fecal transplantation because they’ve heard of its success,” said Thomas Louie, MD, professor of medicine at the University of Calgary, Alberta, and lead author of the pill study. “Many people might find the idea of fecal transplantation off-putting, but those with recurrent infection are thankful to have a treatment that works.”
Indeed, additional research being presented at the meeting showed patients who received fecal transplantation through a tube in the nose were highly satisfied with the treatment, and said they would likely recommend it to a friend.
Fecal Transplantation by Pill
University of Calgary researchers reported a 100 percent success rate – none of the 27 patients who took the tablet-sized pills had a recurrence of C. diff, even though all of them previously had had at least four bouts of the infection. Patients ingested between 24 and 34 capsules containing fecal bacteria, often donated by family members.
To make the pills, researchers processed the feces until it contained only bacteria, and then encapsulated the bacterial concentrate inside three layers of gelatin capsule. This ensured the pills wouldn’t leak or disintegrate until they were past the stomach and into the small intestine – a potential advantage over other methods because it covers more of the GI tract, does not involve invasive and more costly procedures, and is more comfortable for patients, Dr. Louie said.
Dr. Louie said he first made pills for fecal transplantation when one patient failed to respond to the enema method on two occasions and also could not tolerate a nasal tube for medical reasons. The pills are made individually.
“The pills are a one-shot deal and seem to work. They are easier for patients and are well-tolerated,” said Dr. Louie. “It’s an exciting development in the field and could possibly even be used to maintain the balance of bacteria in the GI system in patients at risk for C. diff.””
Patient Satisfaction of Fecal Transplantation
In the study of fecal transplantation tolerance, researchers surveyed 28 patients three months after they had undergone the treatment through a tube fed through the nose and GI system to the small intestine. On a scale of one to 10, average patient scores were: 9.6 for overall satisfaction; 9.9 for ease; and 9.9 for likelihood of recommending the procedure to a family member or friend.
“Patients with C. diff often have 20 or more stools a day, which seriously affects quality of life and so they are very open to this treatment,” said Ravi Kamepalli, MD, an infectious diseases physician at the Regional Infectious Disease-Infusion Center, Lima, Ohio, and lead author of the study. “Human beings are 90 percent bacteria and once that balance is altered with antibiotics, opportunistic infections can cause serious problems. All we are doing with this treatment is resetting the balance.”
The Latest Bing News on:
Clostridium difficile
- How Does Fidaxomicin Work?on July 25, 2024 at 2:28 pm
For these reasons, before you start taking fidaxomicin it is important that your doctor knows: If you are pregnant or breastfeeding. If you have any problems with the way your liver works or any ...
- CDC Warns of Shortage of Bottles Needed for Crucial Blood Testson July 24, 2024 at 11:31 pm
Hospitals and clinical laboratories across the United States are facing a critical shortage of bottles used to culture blood samples, federal health officials report. Without the ability to culture ...
- Idorsia announces financial results for the first half 2024on July 24, 2024 at 6:00 pm
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 25, 2024 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first half of 2024. Business highlights Viatris ...
- Hospitals, labs, and health departments try to cope with blood culture bottle shortageon July 23, 2024 at 4:28 pm
The CDC sent an alert Tuesday about a shortage of blood culture medium bottles that could last into September. Hospitals and labs are trying to stretch supplies.
- Man cut in half by forklift explains 'gross' medical procedure he had to go through to heal part of his bodyon July 19, 2024 at 8:48 am
When a man was cut in half while at work, he had to undergo an uncomfortable treatment during the healing process, which he calls ‘gross’. When Loren Schauers was going about his day at work, he was ...
- RSV monoclonal antibody nirsevimab 83% effective in babies, data revealon July 15, 2024 at 9:18 am
The effectiveness of nirsevimab against RSV-associated bronchiolitis leading to pediatric ICU admission was 70%.
- Promising findings for doctor-led penicillin allergy delabelingon July 11, 2024 at 2:03 pm
Mislabeling patients as allergic to penicillin can lead to antibiotics treatments that aren't as effective and problems from overuse of broad-spectrum drugs.
- The Clostridium Difficile (C. Diff) Bacteriaon July 9, 2024 at 5:00 pm
It's in the air, water, soil, and the feces of humans and animals. Clostridium difficile (C. diff) is a highly contagious bacterial infection of the colon. It's typically caused by taking certain ...
- Clostridium difficile Infectionon May 2, 2024 at 5:00 pm
Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.
- Page settingson January 9, 2024 at 8:03 pm
Source: Focus Medica. Infection of the large intestine (colon) caused by the bacteria Clostridium difficile. Long-term use of antibiotics reduces the normal bacterial population in the intestine ...
The Latest Google Headlines on:
Clostridium difficile
[google_news title=”” keyword=”Clostridium difficile” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Fecal transplants
- Fecal microbiota transplants can boost the effectiveness of immunotherapy in gastrointestinal cancerson July 25, 2024 at 6:18 pm
Findings from a small, proof-of-concept clinical trial have suggested that fecal microbiota transplants (FMTs) can boost the effectiveness of immunotherapy in a range of gastrointestinal cancers. In ...
- Clinical trial: Fecal matter transplant helps half of patients with GI cancers overcome immunotherapy resistanceon July 25, 2024 at 8:00 am
Findings from a small, proof-of-concept clinical trial have suggested that fecal microbiota transplants (FMTs) can boost the effectiveness of immunotherapy in a range of gastrointestinal cancers.
- The Skinny on What We Know About the Microbiome and Obesityon July 24, 2024 at 6:06 am
Mayo Clinic researcher Sahil Khanna discussed the links between obesity and the microbiome, the potential of microbiome therapeutics, and future avenues for research.
- Fecal immunochemical test screening found to lower risk of death from colorectal canceron July 23, 2024 at 11:23 am
Screening with fecal immunochemical tests (FITs) lowers the risk of dying from colorectal cancer (CRC), according to a study published online July 19 in JAMA Network Open.
- Cancer Therapy and The Intestinal Microbiomeon July 23, 2024 at 6:00 am
Secrets in the intestinal microbiome may shed light on how to enhance cancer immunotherapies such as checkpoint inhibitors.
- In which disease is 'fecal' transplant necessary? What is its complete process?on July 20, 2024 at 1:21 am
A 50-year-old man from England, Rick, has undergone a fecal microbiota transplant (FMT) at the University of Birmingham to treat his life-th..|News Track ...
- What fat cats on a diet may tell us about obesity in humanson July 17, 2024 at 7:32 am
Pet cats may be excellent animal models for the study of obesity origins and treatment in humans, a new study of feline gut microbes suggests—and both species would likely get healthier in the ...
- Analyzing the Composition of Fecal Microbiota for the Prediction of reCDIon July 16, 2024 at 6:36 am
The following is a summary of “Fecal microbiota composition is a better predictor of recurrent Clostridioides difficile infection than clinical factors in a prospective, multicentre cohort study,” ...
- Fecal Transplants Saved My Life After I Almost Died of C. diffon July 12, 2024 at 7:30 am
This is my life and this is what I have to deal with. I ended up needing my first fecal microbiota transplant (FMT) in 2016. It was such a new procedure at the time that the FDA still considered it ...
- Fecal Transplants Saved My Life After I Almost Died of C. diffon July 12, 2024 at 7:30 am
This is my life and this is what I have to deal with. I ended up needing my first fecal microbiota transplant (FMT) in 2016. It was such a new procedure at the time that the FDA still considered ...
The Latest Google Headlines on:
Fecal transplants
[google_news title=”” keyword=”fecal transplants” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]